Method Sign up free

Borrower record · Q2 2026

Neurolens

As filed by Trinity Capital Inc. · period end 30 June 2026No sector — one filer, nothing to corroborate

Trinity Capital Inc. is the only BDC lending to Neurolens: $35.5m across two positions at Q2 2026, marked at par. The filed maturities run to October 2028.

Filed fair value
$35.5m
2 funded positions
Aggregate mark
100.5c
cost filed on all 2 positions
Maturities to
2028
one date, 1 October 2028
Periods on record
5
Q2 2025 → Q2 2026

How this total is counted

Pricing as filed

2 floating tranches · SOFR

350bp on all 2 floating tranches — every filer reports the same spread.

Rate structure

Floating, on all 2 positions whose interest type a filer disclosed.

Maturity profile

all 2 funded positions dated
2028
$35.5m

2.3 years to maturity, weighted by fair value across the 2 dated positions.

Filed over time

5 periods · aggregate only

Filed fair value

$35.7m
Q2 2025
$35.7m
Q3 2025
$35.6m
Q4 2025
$35.6m
Q1 2026
$35.5m
Q2 2026

Aggregate marknot to zero

102.1c
Q2 2025
101.8c
Q3 2025
101.1c
Q4 2025
101.1c
Q1 2026
100.5c
Q2 2026

Q2 2025, Q3 2025, Q4 2025, Q1 2026, Q2 2026 — every filer reporting the borrower at each period, aggregated. No lender is separated out at any period.

Credit flags

The filer reports no position on non-accrual, and no filed tranche pays in kind.

Not in the filings

Sign up for free

Tell me when this changes.

One lender reports Neurolens today. We will email you when a second one does, when Trinity Capital Inc.'s mark moves, or when the position leaves the schedule.

Every filing behind this page

1 filer · Q2 2026
FilerCIKFormPeriodFiledAccession
Trinity Capital Inc. (TRIN)000178610810-Q2026-06-302026-08-050001193125-26-333907

Related borrowers

Same lender